Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2015 | 12-2014 | 09-2014 | 12-2013 | 09-2013 | |
| Sales | 5,219 | 0 | 9,051 | 9,051 | 9,051 |
| Gross Profit | 5,219 | 2,930 | 9,051 | 9,051 | 9,051 |
| Operating Expenses | 51,782 | 12,906 | 21,443 | 7,318 | 7,318 |
| Operating Income | -46,563 | -12,906 | -12,392 | 1,732 | 1,732 |
| Interest Expense | 2,297 | 0 | 901 | 901 | 901 |
| Other Income | 0 | 0 | 0 | -14,125 | -14,125 |
| Pre-tax Income | -48,860 | -12,906 | -13,294 | -13,294 | -13,294 |
| Income Tax | -190 | 0 | 439 | 439 | 439 |
| Net Income Continuous | -48,670 | -12,906 | -13,733 | -13,733 | -13,733 |
| Minority Interests | -1,277 | 0 | N/A | 0 | N/A |
| Net Income | $-47,393 | $-12,906 | $-13,733 | $-13,733 | $-13,733 |
| EPS Basic Total Ops | -868.80 | N/A | -388.80 | N/A | N/A |
| EPS Basic Continuous Ops | -798.36 | N/A | -258.19 | N/A | N/A |
| EPS Diluted Total Ops | -868.80 | N/A | -388.80 | N/A | N/A |
| EPS Diluted Continuous Ops | -798.36 | N/A | -258.19 | N/A | N/A |
| EBITDA(a) | $-44,738 | $-12,906 | $-11,514 | $1,732 | $1,732 |